| __timestamp | Regeneron Pharmaceuticals, Inc. | argenx SE |
|---|---|---|
| Wednesday, January 1, 2014 | 1271353000 | 15411924 |
| Thursday, January 1, 2015 | 1620577000 | 22593274 |
| Friday, January 1, 2016 | 2052295000 | 33173050 |
| Sunday, January 1, 2017 | 2075142000 | 62224159 |
| Monday, January 1, 2018 | 2186100000 | 95607434 |
| Tuesday, January 1, 2019 | 3036600000 | 221269028 |
| Wednesday, January 1, 2020 | 2735000000 | 400745069 |
| Friday, January 1, 2021 | 2908100000 | 580520000 |
| Saturday, January 1, 2022 | 3592500000 | 663366000 |
| Sunday, January 1, 2023 | 4439000000 | 755113687 |
| Monday, January 1, 2024 | 5132000000 |
In pursuit of knowledge
In the competitive world of biotechnology, innovation is the lifeblood of success. Over the past decade, Regeneron Pharmaceuticals, Inc. and argenx SE have been at the forefront of this race, investing heavily in research and development (R&D). From 2014 to 2023, Regeneron consistently outpaced argenx, with R&D expenses growing by an impressive 250%, peaking in 2023. In contrast, argenx's R&D spending surged by nearly 4,800% over the same period, reflecting its rapid growth and commitment to innovation. While Regeneron's investment in 2023 was nearly six times that of argenx, the latter's exponential growth trajectory is noteworthy. This data highlights the strategic priorities of these companies and underscores the dynamic nature of the biotech industry. As they continue to push the boundaries of medical science, their investments in R&D will be crucial in shaping the future of healthcare.
Research and Development Expenses Breakdown: Zoetis Inc. vs argenx SE
Regeneron Pharmaceuticals, Inc. or United Therapeutics Corporation: Who Invests More in Innovation?
Research and Development Investment: Regeneron Pharmaceuticals, Inc. vs Corcept Therapeutics Incorporated
Analyzing R&D Budgets: Regeneron Pharmaceuticals, Inc. vs ADMA Biologics, Inc.
Research and Development Investment: Regeneron Pharmaceuticals, Inc. vs Xenon Pharmaceuticals Inc.
Who Prioritizes Innovation? R&D Spending Compared for Regeneron Pharmaceuticals, Inc. and Novavax, Inc.
Comparing Innovation Spending: argenx SE and Alpine Immune Sciences, Inc.
argenx SE or Viking Therapeutics, Inc.: Who Invests More in Innovation?
argenx SE or CRISPR Therapeutics AG: Who Invests More in Innovation?
Research and Development: Comparing Key Metrics for argenx SE and Bausch Health Companies Inc.
Comparing Innovation Spending: argenx SE and ACADIA Pharmaceuticals Inc.
Research and Development Expenses Breakdown: argenx SE vs Soleno Therapeutics, Inc.